How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

Por Louie, Thomas J.
Publicado em 2005

Clostridium difficile infection in hospitals: risk factors and responses

Por Louie, Thomas J., Meddings, Jon
Publicado em 2004

OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection

Por Louie, Thomas J., Emery, Judy, Krulicki, Walter, Byrne, Brendan, Mah, Manuel
Publicado em 2009

Rapid Microbiological Assay for Chloramphenicol and Tetracyclines

Por Louie, Thomas J., Tally, Francis P., Bartlett, John G., Gorbach, Sherwood L.
Publicado em 1976

Fidaxomicin Attains High Fecal Concentrations With Minimal Plasma Concentrations Following Oral Administration in Patients With Clostridium difficile Infection

Por Sears, Pamela, Crook, Derrick W., Louie, Thomas J., Miller, Mark A., Weiss, Karl
Publicado em 2012

Sustained Clinical Response as an Endpoint in Treatment Trials of Clostridium difficile-Associated Diarrhea

Por Johnson, Stuart, Gerding, Dale N., Louie, Thomas J., Ruiz, Nancy M., Gorbach, Sherwood L.
Publicado em 2012

Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI

Por Louie, Thomas J., Cannon, Kris, Byrne, Brendan, Emery, Judy, Ward, Linda, Eyben, Melissa, Krulicki, Walter
Publicado em 2012

Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin

Por Cornely, Oliver A., Miller, Mark A., Louie, Thomas J., Crook, Derrick W., Gorbach, Sherwood L.
Publicado em 2012

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

Por Lee, Christine, Louie, Thomas J., Weiss, Karl, Valiquette, Louis, Gerson, Marvin, Arnott, Wendy, Gorbach, Sherwood L.
Publicado no Can J Infect Dis Med Microbiol (2016)

Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada

Por MacCannell, Duncan R., Louie, Thomas J., Gregson, Dan B., Laverdiere, Michel, Labbe, Annie-Claude, Laing, Felicia, Henwick, Scott
Publicado em 2006

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection

Por Dubberke, Erik R., Mullane, Kathleen M., Gerding, Dale N., Lee, Christine H., Louie, Thomas J., Guthertz, Harriet, Jones, Courtney
Publicado no Open Forum Infect Dis (2016)

Development of a Health-Related Quality of Life Questionnaire (HRQL) for patients with Extremity Soft Tissue Infections (ESTI)

Por Storck, Aric J, Laupland, Kevin B, Read, Ronald R, Mah, Manuel W, Gill, John M, Nevett, Deborah, Louie, Thomas J
Publicado em 2006

Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New bla(IMP) Allele, bla(IMP-7)

Por Gibb, Alan Patrick, Tribuddharat, Chanwit, Moore, Richard A., Louie, Thomas J., Krulicki, Wally, Livermore, David M., Palepou, Marie-France I., Woodford, Neil
Publicado em 2002

Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections

Por Mullane, Kathleen M., Miller, Mark A., Weiss, Karl, Lentnek, Arnold, Golan, Yoav, Sears, Pamela S., Shue, Youe-Kong, Louie, Thomas J., Gorbach, Sherwood L.
Publicado em 2011

Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in a Pediatric Heart Transplant Patient

Por Flannigan, Kyle L., Rajbar, Taylor, Moffat, Andrew, McKenzie, Leanna S., Dicke, Frank, Rioux, Kevin, Workentine, Matthew L., Louie, Thomas J., Hirota, Simon A., Greenway, Steven C.
Publicado no Front Cardiovasc Med (2017)

Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis

Por Bow, Eric J, Pater, Joseph L, Louie, Thomas J, Feld, Ronald, Mandell, Lionel, Robson, Hugh G, Chow, Anthony, Belch, Andrew, Miedzinski, Lilly, Paul, Nancy, Elliott, Catherine R, Willan, Andrew R
Publicado em 1992

Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials

Por Crook, Derrick W., Walker, A. Sarah, Kean, Yin, Weiss, Karl, Cornely, Oliver A., Miller, Mark A., Esposito, Roberto, Louie, Thomas J., Stoesser, Nicole E., Young, Bernadette C., Angus, Brian J., Gorbach, Sherwood L., Peto, Timothy E. A.
Publicado em 2012